Ciprofloxacin-resistant Escherichia coli in hospital wastewater of Bangladesh and prediction of its mechanism of resistance

Akter, Farhima; Amin, M.; Osman, Khan; Anwar, M.; Karim, M.; Hossain, M.
March 2012
World Journal of Microbiology & Biotechnology;Mar2012, Vol. 28 Issue 3, p827
Academic Journal
Hospital and agriculture wastewater is mostly responsible for causing environmental pollution by spreading un-metabolized antibiotics and resistant bacteria, especially in Bangladesh. Here, we studied the influence of the most frequently prescribed antibiotic, fluoroquinolone (~72%), on the development of antibiotic resistance in Escherichia coli. Out of 300, 24 ciprofloxacin resistant E. coli isolates were selected for the study that showed the MBC higher than expected (600 μg/mL). Here, we profiled plasmid, sequenced gyr genes, screened mutations and analyzed the effect of mutation on drug-protein interaction through molecular docking approach. We found that (1) out of 10, most of them (n = 7) had large plasmid(s); (2) all ciprofloxacin-resistant isolates had gyrA double mutations (S83L and D87Y); (3) no isolate had qnr gene; and (4) docking of ciprofloxacin with DNA gyrase A subunit suggests that acquisition of double mutation leads to alteration of the ciprofloxacin binding pocket.


Related Articles

  • Identification of the likely translational start of Mycobacterium tuberculosis GyrB. Karkare, Shantanu; Brown, Amanda C.; Parish, Tanya; Maxwell, Anthony // BMC Research Notes;2013, Vol. 6 Issue 1, p1 

    Background: Bacterial DNA gyrase is a validated target for antibacterial chemotherapy. It consists of two subunits, GyrA and GyrB, which form an A2B2 complex in the active enzyme. Sequence alignment of Mycobacterium tuberculosis GyrB with other bacterial GyrBs predicts the presence of 40...

  • Functional Analysis of Biosynthetic Genes of Aminocoumarins and Production of Hybrid Antibiotics. Shu-Ming Li; Lutz Heide // Current Medicinal Chemistry - Anti-Infective Agents;Dec2004, Vol. 3 Issue 4, p279 

    The aminocoumarin antibiotics novobiocin, clorobiocin and coumermycin A1 are potent inhibitors of DNA gyrase. They compete with ATP for binding to the B subunit of this enzyme and inhibit the ATP-dependent DNA supercoiling catalysed by gyrase. Cloning, sequencing and analysis of the biosynthetic...

  • Emergence and maintenance of multidrug-resistant Escherichia coli of canine origin harbouring a blaCMY-2-IncI1/ST65 plasmid and topoisomerase mutations. Vingopoulou, E. I.; Siarkou, V. I.; Batzias, G.; Kaltsogianni, F.; Sianou, E.; Tzavaras, I.; Koutinas, A.; Saridomichelakis, M. N.; Sofianou, D.; Tzelepi, E.; Miriagou, V. // Journal of Antimicrobial Chemotherapy (JAC);Aug2014, Vol. 69 Issue 8, p2076 

    Objectives To characterize the mechanisms implicated in fluoroquinolone (FQ) and expanded-spectrum cephalosporin (ESC) resistance in three clinical and seven faecal multidrug-resistant (MDR; resistant to at least three antimicrobial classes) Escherichia coli isolates from a dog with atopic...

  • Evaluating the genotoxicity of topoisomerase-targeted antibiotics. Smart, Daniel J.; Lynch, Anthony M. // Mutagenesis;May2012, Vol. 27 Issue 3, p359 

    Antibiotics like fluoroquinolones (FQs) that target bacterial type II topoisomerases pose a potential genotoxic risk due to interactions with mammalian topoisomerase II (TOPO II) counterparts. Inhibition of TOPO II can lead to the generation of clastogenic DNA double-strand breaks (DSBs) that...

  • Molecular mechanisms of antimicrobial resistance in fecal Escherichia coli of healthy dogs after enrofloxacin or amoxicillin administration.  // Canadian Journal of Microbiology;Nov2012, Vol. 58 Issue 11, p1288 

    Escherichia coli respond to selective pressure of antimicrobial therapy by developing resistance through a variety of mechanisms. The purpose of this study was to characterize the genetic mechanisms of antimicrobial resistance in fecal E. coli after the routine use of 2 popular antimicrobials....

  • Multiple modes of Escherichia coli DNA gyrase activity revealed by force and torque. Nöllmann, Marcelo; Stone, Michael D.; Bryant, Zev; Gore, Jeff; Crisona, Nancy J.; Hong, Seok-Cheol; Mitelheiser, Sylvain; Maxwell, Anthony; Bustamante, Carlos; Cozzarelli, Nicholas R. // Nature Structural & Molecular Biology;Apr2007, Vol. 14 Issue 4, p264 

    E. coli DNA gyrase uses the energy of ATP hydrolysis to introduce essential negative supercoils into the genome, thereby working against the mechanical stresses that accumulate in supercoiled DNA. Using a magnetic-tweezers assay, we demonstrate that small changes in force and torque can switch...

  • Promoter protection by a transcription factor acting as a local topological homeostat. Rochman, Mark; Aviv, Michal; Glaser, Gad; Muskhelishvili, Georgi // EMBO Reports;Apr2002, Vol. 3 Issue 4, p355 

    Binding of the Escherichia coli global transcription factor FIS to the upstream activating sequence (UAS) of stable RNA promoters activates transcription on the outgrowth of cells from stationary phase. Paradoxically, while these promoters require negative supercoiling of DNA for optimal...

  • DNA Topoisomerase II Structures and Anthracycline Activity: Insights into Ternary Complex Formation. Dal Ben, D.; Palumbo, M.; Zagotto, G; Capranico, G.; Moro, S. // Current Pharmaceutical Design;Sep2007, Vol. 13 Issue 27, p2766 

    DNA Topoisomerase II (Top2) is an essential nuclear enzyme that regulates the topological state of the DNA, and a target of very effective anticancer drugs including anthracycline antibiotics. Even though several aspects of drug activity against Top2 are understood, the drug receptor site is not...

  • Estimate of the genomic mutation rate deleterious to overall fitness in E. coli. Kibota, Travis T.; Lynch, Michael // Nature;6/20/1996, Vol. 381 Issue 6584, p694 

    Estimates the genomic mutation rate harmful to overall fitness in the microbe Escherichia coli. Use of fifty genetically identical E. coli lines; Comparison to estimates of the genomic deleterious-mutation rate for viability in Drosophila melanogaster.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics